Full Press Release Details
GAITHERSBURG, Md., Aug. 27, 2025 (GLOBE NEWSWIRE) -- Elutia Inc. (Nasdaq: ELUT) (“Elutia”), a pioneer in drug-eluting biomatrix technologies, today announced that Dr. Randy Mills, President and Chief Executive Officer, and Matt Ferguson, Chief Financial Officer, will participate in the following upcoming investor conferences in New York:
Cantor Global Healthcare ConferenceFormat:Fireside Chat and 1x1 MeetingsFireside Chat Date and Time:Thursday, September 4, 2025, 9:45 a.m. ETWebcast Link:Click Here
H.C. Wainwright 27th Annual Global Investment ConferenceFormat:Presentation and 1x1 MeetingsPresentation Date and Time:Wednesday, September 10, 2025, 9:30 a.m. ETWebcast Link:Click Here
Lake Street Capital Markets 9th Annual Best Ideas Growth ConferenceFormat:1x1 MeetingsDate:Thursday, September 11, 2025
Institutional investors interested in scheduling a meeting may contact their Cantor, H.C. Wainwright, or Lake Street representative or emailIR@elutia.com.
About ElutiaElutia develops and commercializes drug-eluting biomatrix products to improve compatibility between medical devices and the patients who need them. With a growing population in need of implantable technologies, Elutia’s mission is humanizing medicine so patients can thrive without compromise. For more information, visitwww.Elutia.com.
Investors:Matt SteinbergFINN Partnersmatt.steinberg@finnpartners.com
This press release was published by a CLEAR® Verified individual.